Table 1.

Patient demographics and clinical characteristics (N = 568)

Median age, y63
Median body surface area, m21.90
WHO performance status
 No data20.3
Site of primary tumor
 No data30.5
Previous adjuvant therapy
Treatment arm
 CB group (without cetuximab)28149
 CBC group (with cetuximab)28751
Median number of treatment courses10

Abbreviation: WHO, World Health Organization.

  • aOnly one patient received zero courses and was accidently included in the analysis. All other patients received 1 or more courses of treatment.